NeuroImmunology
11.3K views | +4 today
Your new post is loading...
Your new post is loading...
Scooped by Gilbert C FAURE
January 19, 2015 1:33 PM
Scoop.it!

Data suggest link between likelihood, onset of multiple sclerosis, uveitis | Ophthalmology

Data suggest link between likelihood, onset of multiple sclerosis, uveitis | Ophthalmology | NeuroImmunology | Scoop.it
Ophthalmology | CHICAGO — Nearly 60% of patients with multiple sclerosis and uveitis were diagnosed with each disease within a 5-year period, according to data presented here at the American Academy of Ophthalmology meeting.Researchers included 24...
No comment yet.
Scooped by Gilbert C FAURE
January 17, 2015 2:21 PM
Scoop.it!

Neurology® Neuroimmunology & Neuroinflammation

Neurology® Neuroimmunology & Neuroinflammation | NeuroImmunology | Scoop.it
Get Neurology® Neuroimmunology & Neuroinflammation on the App Store. See screenshots and ratings, and read customer reviews.
No comment yet.
Scooped by Gilbert C FAURE
January 17, 2015 2:14 PM
Scoop.it!

Science News / Integrin alpha L controls the homing of regulatory T cells during CNS autoimmunity in the absence of integrin alpha 4

Article Abstract: Experimental autoimmune encephalomyelitis (EAE), the animal model of multiple sclerosis (MS), results from an autoimmune attack of the central nervous system (CNS) by effector T helper (Th) 1 and Th17 cells.
No comment yet.
Scooped by Gilbert C FAURE from AUTOIMMUNITY
January 15, 2015 3:24 AM
Scoop.it!

Autoimmune Diseases Masquerading as Psychiatric Disorders- A Paradigm Shift in Psychiatry

Autoimmune Diseases Masquerading as Psychiatric Disorders- A Paradigm Shift in Psychiatry | NeuroImmunology | Scoop.it
Autoimmune diseases result in the production of antibodies that can attack the brain to produce psychiatric symptoms. It is important to diagnose these disorders accurately.
No comment yet.
Scooped by Gilbert C FAURE
January 14, 2015 1:21 PM
Scoop.it!

Autophagy Is Involved in the Reduction of Myelinating Schwann Cell Cytoplasm during Myelin Maturation of the Peripheral Nerve

Autophagy Is Involved in the Reduction of Myelinating Schwann Cell Cytoplasm during Myelin Maturation of the Peripheral Nerve | NeuroImmunology | Scoop.it
by So Young Jang, Yoon Kyung Shin, So Young Park, Joo Youn Park, Seo-Hee Rha, Jong Kuk Kim, Hye Jeong Lee, Hwan Tae Park
Peripheral nerve myelination involves dynamic changes in Schwann cell morphology and membrane structure.
No comment yet.
Scooped by Gilbert C FAURE from Alzheimer's Disease R&D Review
January 13, 2015 2:26 PM
Scoop.it!

Eph receptors: New players in Alzheimer's disease pathogenesis

Abstract

Alzheimer's disease (AD) is devastating and leads to permanent losses of memory and other cognitive functions. Although recent genetic evidences strongly argue for a causative role of Aβ in AD onset and progression (Jonsson et al., 2012), its role in AD etiology remains a matter of debate. However, even if not the sole culprit or pathological trigger, genetic and anatomical evidences in conjunction with numerous pharmacological studies, suggest that Aβ peptides, at least contribute to the disease. How Aβ contributes to memory loss remains largely unknown. Soluble Aβ species referred to as Aβ oligomers have been shown to be neurotoxic and induce network failure and cognitive deficits in animal models of the disease. In recent years, several proteins were described as potential Aβ oligomers receptors, amongst which are the receptor tyrosine kinases of Eph family. These receptors together with their natural ligands referred to as ephrins have been involved in a plethora of physiological and pathological processes, including embryonic neurogenesis, learning and memory, diabetes, cancers and anxiety. Here we review recent discoveries on Eph receptors-mediated protection against Aβ oligomers neurotoxicity as well as their potential as therapeutic targets in AD pathogenesis.

  


Via Krishan Maggon
Krishan Maggon 's curator insight, January 11, 2015 4:37 AM

Neurobiology of Disease

Volume 73, January 2015, Pages 137–149

Review Eph receptors: New players in Alzheimer's disease pathogenesisMoustapha Cissé, , Frédéric Checler,   doi:10.1016/j.nbd.2014.08.028

Scooped by Gilbert C FAURE from Alzheimer's Disease R&D Review
January 12, 2015 5:18 AM
Scoop.it!

A review on Alzheimer's disease pathophysiology and its management: an update

A review on Alzheimer's disease pathophysiology and its management: an update | NeuroImmunology | Scoop.it
Abstract

Alzheimer's disease acknowledged as progressive multifarious neurodegenerative disorder, is the leading cause of dementia in late adult life. Pathologically it is characterized by intracellular neurofibrillary tangles and extracellular amyloidal protein deposits contributing to senile plaques. Over the last two decades, advances in the field of pathogenesis have inspired the researchers for the investigation of novel pharmacological therapeutics centered more towards the pathophysiological events of the disease. Currently available treatments i.e. acetylcholinesterase inhibitors (rivastigmine, galantamine, donepezil) and N-methyl D-aspartate receptor antagonist (memantine) contribute minimal impact on the disease and target late aspects of the disease. These drugs decelerate the progression of the disease, provide symptomatic relief but fail to achieve a definite cure. While the neuropathological features of Alzheimer's disease are recognized but the intricacies of the mechanism have not been clearly defined. This lack of understanding regarding the pathogenic process may be the likely reason for the non-availability of effective treatment which can prevent onset and progression of the disease. Owing to the important progress in the field of pathophysiology in the last couple of years, new therapeutic targets are available that should render the underlying disease process to be tackled directly. In this review, authors will discusses the different aspects of pathophysiological mechanisms behind Alzheimer's disease and its management through conventional drug therapy, including modern investigational therapeutic strategies, recently completed and ongoing.


Via Krishan Maggon
Krishan Maggon 's curator insight, January 11, 2015 4:29 AM
Pharmacological Reports

Volume 67, Issue 2, April 2015, Pages 195–203

Review article A review on Alzheimer's disease pathophysiology and its management: an updateAnil Kumar, , , Arti Singh, Ekavali  doi:10.1016/j.pharep.2014.09.004
Scooped by Gilbert C FAURE
January 10, 2015 2:47 PM
Scoop.it!

Comparable autoantibody serum levels against amyloid- and inflammat... - PubMed - NCBI

PLoS One. 2014 Feb 21;9(2):e88604. doi: 10.1371/journal.pone.0088604. eCollection 2014.
No comment yet.
Scooped by Gilbert C FAURE
January 10, 2015 4:38 AM
Scoop.it!

Practical Management of Bevacizumab-Related Toxicities in Glioblastoma

Practical Management of Bevacizumab-Related Toxicities in Glioblastoma | NeuroImmunology | Scoop.it
The Oncologist is a journal devoted to medical and practice issues for surgical, radiation, and medical oncologists.
No comment yet.
Scooped by Gilbert C FAURE
January 9, 2015 2:45 PM
Scoop.it!

Interferon Beta and Vitamin D Synergize to Induce Immunoregulatory Receptors on Peripheral Blood Monocytes of Multiple Sclerosis Patients

Interferon Beta and Vitamin D Synergize to Induce Immunoregulatory Receptors on Peripheral Blood Monocytes of Multiple Sclerosis Patients | NeuroImmunology | Scoop.it
by Anne Waschbisch, Nicholas Sanderson, Markus Krumbholz, George Vlad, Diethilde Theil, Stefan Schwab, Mathias Mäurer, Tobias Derfuss
Immunoglobulin-like transcript (ILT) 3 and 4 are inhibitory receptors that modulate immune responses.
No comment yet.
Scooped by Gilbert C FAURE
January 9, 2015 10:52 AM
Scoop.it!

MicroRNA miR-21 is induced by interferon-beta and inhibits IL-12 expression: a novel immunomodulatory mechanism in multiple sclerosis | MS CME Academy

MicroRNA miR-21 is induced by interferon-beta and inhibits IL-12 expression: a novel immunomodulatory mechanism in multiple sclerosis | MS CME Academy | NeuroImmunology | Scoop.it
Mscmeacademy - Sitecore | Dr. Balashov discusses the effect of interferon beta on interleukin-12 in controlling multiple sclerosis symptoms
No comment yet.
Scooped by Gilbert C FAURE
January 6, 2015 3:03 PM
Scoop.it!

Multiple Sclerosis Research: Interleukin-34 affects blood brain barrier

Multiple Sclerosis Research: Interleukin-34 affects blood brain barrier | NeuroImmunology | Scoop.it
RT @GavinGiovannoni: I've just posted on my Blog about: Interleukin-34 affects blood brain barrier http://t.co/bwL3BiTb3G
No comment yet.
Scooped by Gilbert C FAURE from Vectorology - GEG Tech top picks
January 3, 2015 1:39 PM
Scoop.it!

Selective Lentiviral Gene Delivery to CD133-Expressing Human Glioblastoma Stem Cells

Selective Lentiviral Gene Delivery to CD133-Expressing Human Glioblastoma Stem Cells | NeuroImmunology | Scoop.it
PLOS ONE: an inclusive, peer-reviewed, open-access resource from the PUBLIC LIBRARY OF SCIENCE. Reports of well-performed scientific studies from all disciplines freely available to the whole world.

Via BigField GEG Tech
BigField GEG Tech's curator insight, December 31, 2014 6:23 AM

The authors design a CD133-LV, a lentiviral vector presenting a single chain antibody against CD133 on its envelope, as a vehicle for the selective transduction of CD133-expressing GSCs. CD133-LV selectively transduces CD133-expressing cells in intracranial human GBM xenografts in NOD.SCID mice, but spares normal mouse brain tissue, neurons derived from human embryonic stem cells and primary human astrocytes. These findings indicate that CD133-LV represents a novel tool for the selective genetic manipulation of CD133-expressing GSCs, and can be used to answer important questions about how these cells contribute to tumor biology and therapy resistance.


www.geg-tech.com

Scooped by Gilbert C FAURE
January 18, 2015 12:01 PM
Scoop.it!

Role of α-Synuclein in Inducing Innate and Adaptive Immunity in Par... - PubMed - NCBI

J Parkinsons Dis. 2015 Jan 7. [Epub ahead of print]
No comment yet.
Scooped by Gilbert C FAURE
January 17, 2015 2:20 PM
Scoop.it!

New Insights Into Antibody Overlap Syndromes | ...

New Insights Into Antibody Overlap Syndromes | ... | NeuroImmunology | Scoop.it
Be on the lookout for discordance in populations of patients with anti-NMDAR-syndrome, anti-AQP4 antibodies, and anti-MOG antibodies. Here's why.
No comment yet.
Scooped by Gilbert C FAURE
January 15, 2015 2:55 PM
Scoop.it!

A Step Toward Multiple Sclerosis Treatment? Phase 2 ANTI-LINGO-1 Results ... - Multiple Sclerosis News Today

A Step Toward Multiple Sclerosis Treatment? Phase 2 ANTI-LINGO-1 Results ... - Multiple Sclerosis News Today | NeuroImmunology | Scoop.it
A Step Toward Multiple Sclerosis Treatment? Read About How Phase 2 ANTI-LINGO-1 Results Were Recently Announced, and What That Means for MS Patients.
No comment yet.
Scooped by Gilbert C FAURE
January 14, 2015 1:22 PM
Scoop.it!

Autophagy Is Involved in the Reduction of Myelinating Schwann Cell Cytoplasm during Myelin Maturation of the Peripheral Nerve

Autophagy Is Involved in the Reduction of Myelinating Schwann Cell Cytoplasm during Myelin Maturation of the Peripheral Nerve | NeuroImmunology | Scoop.it
by So Young Jang, Yoon Kyung Shin, So Young Park, Joo Youn Park, Seo-Hee Rha, Jong Kuk Kim, Hye Jeong Lee, Hwan Tae Park
Peripheral nerve myelination involves dynamic changes in Schwann cell morphology and membrane structure.
No comment yet.
Scooped by Gilbert C FAURE
January 14, 2015 6:30 AM
Scoop.it!

Cell Death and Differentiation - Role and therapeutic value of dendritic cells in central nervous system autoimmunity

Cell Death and Differentiation - Role and therapeutic value of dendritic cells in central nervous system autoimmunity | NeuroImmunology | Scoop.it
Dendritic cells (DCs) are professional antigen-presenting cells that control the generation of adaptive immunity. Consequently, DCs have a central role in the induction of protective immunity to pathogens and also in the pathogenic immune response responsible for the development and progression of autoimmune disorders. Thus the study of the molecular pathways that control DC development and function is likely to result in new strategies for the therapeutic manipulation of the immune response. In this review, we discuss the role and therapeutic value of DCs in autoimmune diseases, with a special focus on multiple sclerosis.
Gilbert C FAURE's insight:

paper full text

No comment yet.
Scooped by Gilbert C FAURE
January 13, 2015 2:06 PM
Scoop.it!

Just Medical News / Role and therapeutic value of dendritic cells in central nervous system autoimmunity

Article Abstract: from Cell Death and Differentiation - Issue - nature.com science feedsClick Here To Read Full Article Visit Cell Death and Differentiation - Issue - nature.com science feeds for more great articles.
No comment yet.
Scooped by Gilbert C FAURE
January 11, 2015 1:53 PM
Scoop.it!

The blood-brain barrier in neuroimmunology: Tales of separation and assimilation

"The blood-brain barrier in neuroimmunology: Tales of separation and assimilation" http://t.co/GTxaPKoePZ #immunesystem #nervoussystem
Société Francaise d'Immunologie's comment, January 12, 2015 9:31 AM
Neuroimmunology is concerned with the relations between the central nervous and immune systems and with the mechanisms that drive those relations. The blood-brain barrier (BBB) employs mechanisms that both separate and connect these two systems. In fact, the relative immune privilege of the central nervous system (CNS) is largely attributable to the BBB’s ability to prevent the unregulated exchange of immune cells and their secretions between the CNS and blood. Having separated the two systems, the BBB then participates in mechanisms that allow them to influence, communicate, and interact with one another. Likewise, the BBB itself is influenced by immune events that are occurring in the periphery and in the CNS so that these three components (the BBB, the immune system, and the CNS) form neuroimmune axes that adapt to physiological and pathological conditions. To date, four major themes have emerged by which the BBB participates in these neuroimmune axes. The first of these four, the formation of the barrier, acts to separate the immune and central nervous systems. The other three themes provide mechanisms for re-establishing communication: response of the BBB to immunomodulatory molecules (e.g., prostaglandins, cytokines, chemokines, nitric oxide) secreted by immune and CNS cells; the controlled, regulated exchange of chemokines, cytokines, and immune cells between the CNS and the blood (i.e., transport across the BBB); the secretion of immunomodulatory molecules by the BBB, often in a polarized fashion. Taken together, these mechanisms reveal the BBB to be a dynamic, interactive, and adaptable interface between the immune system and the CNS, separating them on the one hand and fostering their interactions on the other hand, adjusting to physiological changes, while being a target for disease processes. This review examines specific examples by which the BBB plays an interactive, defining role in neuroimmunology.

Neuroimmunology is concerned with the relations between the central nervous and immune systems and with the mechanisms that drive those relations. The blood-brain barrier (BBB) employs mechanisms that both separate and connect these two systems. In fact, the relative immune privilege of the central nervous system (CNS) is largely attributable to the BBB’s ability to prevent the unregulated exchange of immune cells and their secretions between the CNS and blood. Having separated the two systems, the BBB then participates in mechanisms that allow them to influence, communicate, and interact with one another. Likewise, the BBB itself is influenced by immune events that are occurring in the periphery and in the CNS so that these three components (the BBB, the immune system, and the CNS) form neuroimmune axes that adapt to physiological and pathological conditions. To date, four major themes have emerged by which the BBB participates in these neuroimmune axes. The first of these four, the formation of the barrier, acts to separate the immune and central nervous systems. The other three themes provide mechanisms for re-establishing communication: response of the BBB to immunomodulatory molecules (e.g., prostaglandins, cytokines, chemokines, nitric oxide) secreted by immune and CNS cells; the controlled, regulated exchange of chemokines, cytokines, and immune cells between the CNS and the blood (i.e., transport across the BBB); the secretion of immunomodulatory molecules by the BBB, often in a polarized fashion. Taken together, these mechanisms reveal the BBB to be a dynamic, interactive, and adaptable interface between the immune system and the CNS, separating them on the one hand and fostering their interactions on the other hand, adjusting to physiological changes, while being a target for disease processes. This review examines specific examples by which the BBB plays an interactive, defining role in neuroimmunology.

Scooped by Gilbert C FAURE
January 10, 2015 2:43 PM
Scoop.it!

Cinnamon Ameliorates Experimental Allergic Encephalomyelitis in Mice via Regulatory T Cells: Implications for Multiple Sclerosis Therapy

Cinnamon Ameliorates Experimental Allergic Encephalomyelitis in Mice via Regulatory T Cells: Implications for Multiple Sclerosis Therapy | NeuroImmunology | Scoop.it
by Susanta Mondal, Kalipada Pahan
Upregulation and/or maintenance of regulatory T cells (Tregs) during an autoimmune insult may have therapeutic efficacy in autoimmune diseases.
No comment yet.
Scooped by Gilbert C FAURE
January 10, 2015 2:55 AM
Scoop.it!

Hematopoietic Cell Transplantation for MS

Hematopoietic Cell Transplantation for MS | NeuroImmunology | Scoop.it
Research from JAMA Neurology — High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation for Relapsing-Remitting Multiple Sclerosis (HALT-MS) — A 3-Year Interim Report
No comment yet.
Scooped by Gilbert C FAURE
January 9, 2015 10:54 AM
Scoop.it!

Natural Killer Cell Subsets in Cerebrospinal Fluid of Patients with... - PubMed - NCBI

Clin Exp Immunol. 2015 Jan 7. doi: 10.1111/cei.12580. [Epub ahead of print]
No comment yet.
Scooped by Gilbert C FAURE
January 7, 2015 2:52 PM
Scoop.it!

CCR2-Dependent Dendritic Cell Accumulation in the Central Nervous System during Early Effector Experimental Autoimmune Encephalomyelitis Is Essential for Effector T Cell Restimulation In Situ and D...

Dendritic cells (DCs)—although absent from the healthy CNS parenchyma—rapidly accumulate within brain and spinal cord tissue during neuroinflammation associated with experimental autoimmune encephalomyelitis (EAE; a mouse model of multiple...
No comment yet.
Scooped by Gilbert C FAURE
January 4, 2015 11:46 AM
Scoop.it!

Letters unravel mystery of the death of Oscar Wilde’s wife

Letters unravel mystery of the death of Oscar Wilde’s wife | NeuroImmunology | Scoop.it
Grandson of Irish dramatist has unearthed medical evidence in private family letters which points to likely cause of death
Gilbert C FAURE's insight:

multiple sclerosis

No comment yet.